2019 Future Healthcare 100 Summit: Exploring the New Increment of Life

Over the past five years, VCBeat has continuously explored and validated patterns underlying the transformation of the healthcare industry, with the “Top 100 Future Healthcare Companies” Forum serving as a platform that encapsulates these emerging trends.

The “Eye of the Storm” in 2016: As the forces of wild, unchecked growth gradually returned to rationality, and as technological breakthroughs and innovations quietly reshaped the healthcare ecosystem, reimagining the full landscape of China’s future healthcare became imperative. Cross-sector collaboration, integration, and breakthrough emerged as a new normal, with the rapidly changing storm slowly settling into a state of equilibrium;

2017 ushered in the “Era of Species Explosion,” injecting new vitality into every medical subsector. Transformations in healthcare service systems, deep advancements in medical technologies, emerging forces in patient acquisition channels, and a new ecosystem within the pharmaceutical and medical device industry all sprang up with remarkable vigor, initiating a fascinating evolutionary journey in the healthcare sector;

In 2018, we proposed aligning ourselves with the sweeping tide of healthcare transformation. Policy shifts, capital flows, and technological innovations each constitute powerful tides; their interaction, influence, and convergence collectively propel healthcare toward its future. “Tide Direction ING” served as the most important guiding principle for that year.

2019: Seeking Incremental Growth in the Wake of the Wave

Amid the technological wave, three major technology clusters are rapidly emerging. The digital health technology cluster, centered on the internet, big data, and artificial intelligence, has become an indispensable incremental force for enhancing healthcare quality, efficiency, and accessibility. Intelligent manufacturing has significantly optimized medical solutions, bringing substantial incremental value to surgery and rehabilitation. Meanwhile, the flourishing life sciences sector—encompassing not only genomics and innovative drugs but also microbiome research and synthetic biology—is redefining life through these new incremental advancements.

Our exploration does not stop here. The outsourcing of hospital cost centers and organizational restructuring, the introduction of enterprise solutions and value chain reconfiguration, humanity’s aspiration for a better life, and the redefinition of relationships between individuals and organizations as well as among individuals—all indicate that the entire healthcare industry system is seeking new growth drivers.

The construction of a multi-tiered financial services system has become the core driving force of the healthcare industry, with capital infusion exerting a significant impact. Complementing this trend are policy developments: the National Health Commission and the National Healthcare Security Administration, both established over a year ago, are rapidly deepening reforms. The duality of data and payment may well become the core operational mechanism of the healthcare system. As challenges such as cost containment, Diagnosis-Related Groups (DRGs), and payment innovation come to the fore, further policy advancements are imminent.

So, what are the systemic variables that will shape the development of the life and health sector over the next decade? We believe it is digitalization.

Digitalization has ushered in a new landscape of possibilities, serving as the key to unlocking incremental growth, which we refer to as the “new growth frontier” for life.

All Things Have a Spirit: “The New Growth of Life” Is About to Unfold.

December 20–22, 2019 (Friday–Sunday), with “The New Growth of Life”-themed 2019 Future Healthcare Top 100 Conference will be held atBeijing · Jiuhua Mountain ResortAs the annual flagship event for discussing trends in the healthcare industry, this conference will comprehensively analyze the future development trajectory of the healthcare sector by examining multiple factors—including the policy landscape, technological environment, and demand potential—thereby driving innovative transformation within the industry.

In this golden age, you will witness how some intriguing minds are seriously contemplating the new growth drivers of the healthcare industry. At the 2019 Future Healthcare 100 Conference, meet these individuals—and become one of them.

The following are197thGuests are listed in chronological order according to the agenda. Given the extensive content and impressive lineup, a complete read will take approximately 10 minutes; we recommend saving this page for later reference. To register quickly, please click the image below.

(Scan the QR code to register and get an instant ¥100 discount)

1. China’s first ranking list focused on innovative healthcare companies that are not publicly listed.From 2016 to 2018, the total valuation of companies listed across three editions exceeded one trillion yuan, with the 2018 list alone surpassing 400 billion yuan. Over the past three years, more than 130 listed companies have secured financing in succession; among the 100 companies on the 2018 list, over 50 obtained new rounds of funding.

2. Executives from high-quality enterprises and pre-IPO companies featured in previous Top 100 lists will attend to deliver speeches and share insights;

3. Founders of top 100 enterprises such as DXY, Haodf, Weimai, and Miao HealthA Deep Deconstruction of How Companies Grow from Small Beginnings to Become Unicorns in the Healthcare Sector: What Factors Drove Their Development at Each Critical Juncture？

4、The 2019 Top 100 Future Healthcare Companies list was released on-site.

VCBeatCo-created with KPMG China，Over 10 senior executives from companies in this field attended and shared their insights; the focus was on product and technological innovation, business model innovation, and service-driven incremental growth.

1. Provide GPs with opportunities for in-depth, face-to-face engagement with global LPs to seek breakthroughs amid the capital winter;

2、More than ten LPs, including China Development Bank, Affix Family Office, Vesalius Biocapital, Star Capital, Shanghai Science and Technology Innovation Fund of Funds, Shengshi Investment, Luolai Home Textiles, China Reinsurance Group, Chongqing Ke Fengtou, Kunyuan Asset Management, and Shuanghu Capital, will attend the summit;

3. Friendly reminder: This summit is a closed-door event, requiring separate registration and approval.

1. The summit will invite over 30 government officials, scholars, investors, and entrepreneurs to explore new growth drivers for China’s health and wellness industry across six key modules;

2、Mao Qun’an, Director of the Department of Planning, Development and Informatization of the National Health Commission, Confirmed to Attend and Deliver a Speech；

3. Deputy Secretary-General of the China Association for Drug Administration ResearchWang Baoting Confirmed to Attend and Deliver a Speech；

4. VCBeat On-Site Release and Interpretation"Future Healthcare Industry Tree Report", this report will provide a panoramic interpretation of the domestic innovative medical and health industry ecosystem;

5、Three Leading Scientists Jointly Explore New Application Scenarios for Three Categories of Foundational Technologies: Digital, Life Sciences, Intelligent Manufacturing, and New Materials；

6、Five Hospital Presidents Jointly Explore New Trends in the Transformation of China’s Public Hospitals and New Awareness Among Physicians；

7. Listed companies, innovative enterprises, and prominent investors discuss the development trends and investment hotspots in the healthcare industry over the next five years.

1、Professor Shi Yuankai, Deputy Director of the National Cancer Center and Vice President of the Cancer Hospital, Chinese Academy of Medical SciencesAttend and deliver a speech;

2. VCBeat and Aimida jointly planned the forum,The forum will feature in-depth discussions centered on three key modules: policies and trends in new drug development, case studies of new drug development, and the application of innovative technologies—such as big data, AI, blockchain, and cloud computing—in new drug development.

1. VCBeat joins hands withBV Baidu Venture CapitalJointly Create an Innovative Health Insurance Forum,Invite unicorn companies in this field to share their innovative achievements on topics such as commercial insurance, payment, medical insurance, and cross-sector collaboration, and explore the significant challenges and opportunities facing innovative payment models;

2. On-site Release and Interpretation"2019 Commercial Health Insurance Report."

1. VCBeat joins hands withForlai Capital, jointly create a health management forum,The forum will primarily focus on how new technologies, new business models, and new concepts can empower the health management industry.

2. Experts in the Field of Health ManagementProfessor Wu Liuxin Attends and Shares Insights。

1. VCBeat Joins Hands withPuhua CapitalJointly Build the Digital Pathology and Precision Diagnostics Forum,InvitationProfessor Bu Hong, Director of the Department of Pathology at West China Hospital, Sichuan University, and a leading figure in China’s pathology community, delivered a keynote address;

2. Focusing on the trends of digitalization, intelligence, and precision in pathology, this session explores hot topics such as integrated solutions for pathological diagnosis, immunohistochemistry technology, next-generation sequencing, and digital PCR, discussing the future trends and practical explorations of pathological diagnosis in the realms of digitalization, intelligence, and precision.

1. VCBeat joins hands withTsinghua University (School of Social Sciences) Nomura Research Institute China Research CenterCo-hosted. Inviting representative enterprises from Japan's health and wellness industry, such asFujifilm, Hitachi Medicaland other senior executives attended the analysis,AnalysisJapan’s Renowned Health Industry: What Are Its Development Experiences? How Do Its Products and Services Differ? How Has It Built Such a Strong Reputation?

2. Simultaneously invite representatives from leading enterprises in China’s health and wellness industry to discuss topics such as promoting mutually beneficial development of the Chinese and Japanese health industries and strengthening cooperation in health investment.

1、Over 20 executives from listed companies attended, sharing insights on transformation and upgrading at key milestones of corporate development, andShare the key strategic layout in the health sector for the new year;

2. Specially CraftedChief Roundtable, inviting chief analysts from Haitong Securities, Tianfeng Securities, GF Securities, Southwest Securities, and CITIC Securities to jointly explore new opportunities for IPOs of medical innovation enterprises;

3. InvitationSanofi, Novartis, Boehringer Ingelheim, Philipsand other renowned multinational corporations, to explore China-style innovation within international healthcare enterprises.

1. VCBeat Joins Hands withInternet Hospital Branch of the Chinese Research Hospital AssociationCo-hosted;In-depth discussions will be conducted across four key modules: new perspectives on the internet hospital model, the shift of internet healthcare into vertical models, the implementation of air medical services, and the boundless extensions of internet healthcare.

2、The 5th Internet Hospital Report Released by VCBeat for the Fourth Consecutive Year, by integrating typical case studies, it analyzes enterprises’ innovations in technology, business models, and management and operations, as well as the specific impacts of these innovations on the efficiency and quality of medical services, thereby systematically, comprehensively, and scientifically presenting the current development status and future trends of China’s internet hospital industry.

1. As policies such as the “4+7 Volume-Based Procurement” are progressively implemented, the pharmaceutical industry is undergoing profound transformations, with an imminent restructuring of the industrial landscape. VCBeat joins hands withChangling CapitalCo-hosting the Pharmaceutical Digital Marketing Forum, we will invite nearly 10 guests to jointly discuss: restructuring of the pharmaceutical industry in the post-“4+7” era, and how digitalization empowers new marketing strategies;

2. On-site Release and Interpretation"Pharmaceutical Digital Transformation Industry Report"。

1. The conference will feature discussions on the analysis of development trends in smart hospitals, interpretation of standards and specifications for smart hospital construction, launch of innovative solutions and products for smart hospitals, and sharing of practical experiences in the informatization of smart hospitals.

2、Zheng Jie, Deputy Director of the Beijing Municipal Medical Insurance CenterAttended the forum and shared insights.

VCBeat in collaboration withLegend CapitalCo-host the forum.Inviting corporate guests from Ren Dong Medicine, Huirui Gene, Sphero Biotech, and Xbiome to focus on cutting-edge biotechnology leading drug development, centering onGenetic Testing, Cell Therapy, Microbiomeand other topics, to jointly explore new technologies, recent advances, and future development trends in the field of biopharmaceutical research and development.

1. VCBeat and Yuanjing Capital Jointly Hosted the Medical Artificial Intelligence Forum;This forum will conduct in-depth discussions on topics such as computer-aided diagnosis, image reconstruction, policy and regulation, commercialization, and natural language processing (NLP);

2、Philips Innovation Center Releases and Interprets "Artificial Intelligence in Healthcare Report" On-Site。

(Scan the QR code to register and get an instant discount of 100 yuan)